• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization.社论：肿瘤相关抗原及其自身抗体，从发现到临床应用。
Front Oncol. 2022 Jul 20;12:970623. doi: 10.3389/fonc.2022.970623. eCollection 2022.
2
Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.评估针对肿瘤相关抗原的血清自身抗体作为肺癌生物标志物的情况。
Tumour Biol. 2017 Oct;39(10):1010428317711662. doi: 10.1177/1010428317711662.
3
Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.抗RalA自身抗体作为人类前列腺癌潜在血清生物标志物的评估与特性分析
Oncotarget. 2016 Jul 12;7(28):43546-43556. doi: 10.18632/oncotarget.9869.
4
Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.用于检测卵巢癌的针对一组15种肿瘤相关抗原的血清自身抗体。
Tumour Biol. 2017 Jun;39(6):1010428317699132. doi: 10.1177/1010428317699132.
5
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.利用免疫蛋白质组学鉴定肿瘤相关抗原（TAA）作为癌症免疫诊断的生物标志物。
Autoimmun Rev. 2013 Oct;12(12):1123-8. doi: 10.1016/j.autrev.2013.06.015. Epub 2013 Jun 24.
6
Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.乳腺癌免疫诊断中针对新型肿瘤相关抗原p90/CIP2A的自身抗体反应
Tumour Biol. 2014 Mar;35(3):2661-7. doi: 10.1007/s13277-013-1350-6. Epub 2014 Jan 8.
7
Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.利用一组多种肿瘤相关抗原来增强卵巢癌免疫诊断中的自身抗体检测。
J Cell Biochem. 2019 Mar;120(3):3091-3100. doi: 10.1002/jcb.27497. Epub 2018 Nov 28.
8
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.肿瘤相关抗原自身抗体作为癌症免疫诊断的生物标志物。
Autoimmun Rev. 2011 Apr;10(6):331-5. doi: 10.1016/j.autrev.2010.12.002. Epub 2010 Dec 15.
9
Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.基于 Oncomine 数据库的肿瘤相关抗原筛选及肺癌自身抗体诊断价值评估。
Clin Immunol. 2020 Jan;210:108262. doi: 10.1016/j.clim.2019.108262. Epub 2019 Oct 17.
10
Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.基于血清蛋白质组分析方法鉴定ENO1作为肿瘤相关抗原及其自身抗体可提高CEA和CYFRA 21-1在非小细胞肺癌检测中的敏感性。
Oncotarget. 2017 May 30;8(22):36664-36673. doi: 10.18632/oncotarget.17067.

引用本文的文献

1
From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.从基础科学到临床实践：蛋白磷酸酶2A癌性抑制剂（CIP2A）/p90在癌症中的作用
Front Genet. 2023 Feb 24;14:1110656. doi: 10.3389/fgene.2023.1110656. eCollection 2023.

本文引用的文献

1
Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer.全基因组衍生的平铺肽阵列检测非小细胞肺癌的预测性自身抗体特征。
Cancer Res. 2019 Apr 1;79(7):1549-1557. doi: 10.1158/0008-5472.CAN-18-1536. Epub 2019 Feb 5.
2
Identification of Serological Biomarkers for Early Diagnosis of Lung Cancer Using a Protein Array-Based Approach.基于蛋白质芯片的方法鉴定用于肺癌早期诊断的血清学生物标志物。
Mol Cell Proteomics. 2017 Dec;16(12):2069-2078. doi: 10.1074/mcp.RA117.000212. Epub 2017 Oct 11.
3
Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.利用血清蛋白质组分析确定血清抗核磷蛋白1自身抗体作为欧美裔和非裔美国前列腺癌患者的潜在生物标志物。
Prostate. 2016 Nov;76(15):1375-86. doi: 10.1002/pros.23217. Epub 2016 Jul 15.
4
Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.使用人类蛋白质组芯片鉴定用于胃癌诊断的血清生物标志物
Mol Cell Proteomics. 2016 Feb;15(2):614-23. doi: 10.1074/mcp.M115.051250. Epub 2015 Nov 23.
5
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.采用免疫组学方法提高肝癌诊断中肿瘤相关自身抗体的检测。
Clin Immunol. 2014 May-Jun;152(1-2):127-39. doi: 10.1016/j.clim.2014.03.007. Epub 2014 Mar 22.
6
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.利用免疫蛋白质组学鉴定肿瘤相关抗原（TAA）作为癌症免疫诊断的生物标志物。
Autoimmun Rev. 2013 Oct;12(12):1123-8. doi: 10.1016/j.autrev.2013.06.015. Epub 2013 Jun 24.
7
Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.利用免疫蛋白质组学鉴定α-烯醇化酶作为肝纤维化中的自身抗原。
J Proteome Res. 2013 Apr 5;12(4):1789-96. doi: 10.1021/pr3011342. Epub 2013 Mar 15.
8
Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.采用蛋白质组学方法鉴定人食管鳞癌相关肿瘤标志物。
J Proteome Res. 2011 Jun 3;10(6):2863-72. doi: 10.1021/pr200141c. Epub 2011 May 3.
9
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.肿瘤相关抗原自身抗体作为肝癌和其他实体瘤的诊断生物标志物。
Expert Rev Mol Diagn. 2010 Apr;10(3):321-8. doi: 10.1586/erm.10.12.
10
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.肿瘤相关抗原自身抗体与异常甲胎蛋白联合增强对肝细胞癌的免疫诊断。
Cancer Lett. 2010 Mar 1;289(1):32-9. doi: 10.1016/j.canlet.2009.07.016. Epub 2009 Aug 15.

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization.

作者信息

Zhang Jianying, Guo Xiangqian, Jin Bilian, Zhu Qing

机构信息

Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, United States.

Department of Preventive Medicine, Institute of Biomedical Informatics, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Basic Medical Sciences, Academy for Advanced Interdisciplinary Studies, Henan University, Kaifeng, China.

出版信息

Front Oncol. 2022 Jul 20;12:970623. doi: 10.3389/fonc.2022.970623. eCollection 2022.

DOI:10.3389/fonc.2022.970623
PMID:35936692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346231/
Abstract
摘要